All Articles

Numerous approaches to treatment of dry AMD are under development.
Ophthalmic Product Development Insights
A discussion of gland mechanisms, how they can go awry and what you can do to nurse them back to health.
Explaining both the demands and potential rewards of a clinical trial can make patients more likely to participate fully in the protocol.
Dr. Hollander joins Ora after 10 years as industry leader at Allergan. Meet Ora’s New Chief Medical Officer at ARVO
Involvement in diagnostic clinical trials can assist you in bringing a new level of expertise to your staff.
Exposure to certain wavelengths of blue light carries potential blinding effects and a link to AMD.
Research has led to better, more diverse ways to reach a diagnosis, let alone more knowledge about DED itself.